Cue Biopharma, Inc. (CUE) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $30.41 (+106.32%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 15, 2024 | Maury Raycroft | Jefferies | $4.00 | -86.8% |
| Jul 26, 2024 | Reni Benjamin | JMP Securities | $2.00 | -93.4% |
| Mar 13, 2024 | Maury Raycroft | Jefferies | $6.00 | -80.3% |
| Nov 20, 2022 | Edward Tenthoff | Piper Sandler | $7.00 | -77.0% |
Top Analysts Covering CUE
CUE vs Sector & Market
| Metric | CUE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.24 | 2.41 |
| Analyst Count | — | 8 | 18 |
| Target Upside | -85.8% | +1150.4% | +14.9% |
| P/E Ratio | -1.69 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1M | $1M | $1M | 1 |
| 2027-12-31 | $1M | $1M | $1M | 1 |
| 2028-12-31 | $1M | $1M | $1M | 1 |
| 2029-12-31 | $1M | $1M | $1M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.58 | $-0.58 | $-0.58 | 1 |
| 2027-12-31 | $-0.60 | $-0.60 | $-0.60 | 1 |
| 2028-12-31 | $-0.51 | $-0.51 | $-0.51 | 1 |
| 2029-12-31 | $-0.52 | $-0.52 | $-0.52 | 1 |
Frequently Asked Questions
What is the analyst consensus for CUE?
The consensus among 0 analysts covering Cue Biopharma, Inc. (CUE) is — with an average price target of $4.33.
What is the highest price target for CUE?
The highest price target for CUE is $7.00, set by Edward Tenthoff at Piper Sandler on 2022-11-20.
What is the lowest price target for CUE?
The lowest price target for CUE is $2.00, set by Reni Benjamin at JMP Securities on 2024-07-26.
How many analysts cover CUE?
0 analysts have issued ratings for Cue Biopharma, Inc. in the past 12 months.
Is CUE a buy or sell right now?
Based on 0 analyst ratings, CUE has a consensus rating of — with a -85.8% upside to the consensus target of $4.33.
What are the earnings estimates for CUE?
Analysts estimate CUE will report EPS of $-0.58 for the period ending 2026-12-31, with revenue estimated at $1M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.